ArticleDiscover oncology2025

Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy.

Ta-Chung Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.